INTERNATIONAL BIOTECHNOLOGY TST PLC

Board/Management Information • Nov 30, 2021

National Storage Mechanism | Additional information

RNS Number : 0468U

Intl. Biotechnology Trust PLC

30 November 2021

30 November 2021

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

("IBT" or the "Company")

Appointment of Non-Executive Director

The Board of the Company is pleased to announce the appointment of Patrick Maxwell as a Non-Executive Director of the Company with effect from 1 January 2022.

Professor Patrick Maxwell is the Regius Professor of Physic and Head of the School of Clinical Medicine at Cambridge University. Patrick has extensive knowledge and experience of the biotechnology sector and has made important discoveries concerning oxygen sensing. He was elected a Fellow of the Academy of Medical Sciences in 2005. He is currently a member of the boards of Scottish Mortgage Investment Trust plc, Cambridge University Health Partners, Cambridge University Hospitals NHS Foundation Trust and Cambridge Enterprise. 

The following additional information is disclosed in accordance with Chapter 9 of the Financial Conduct Authority Listing Rules:

1.   There are no details to be disclosed under Listing Rule 9.6.13.

2.   As at today's date Patrick Maxwell has no beneficial interest in the Ordinary shares of the Company.

As explained in the Company's Annual Report for the year ended 31 August 2021, Dr Véronique Bouchet will retire from the Board at the conclusion of the AGM to be held in December 2021.

For further information contact:

Broker - Numis

Nathan Brown                +44 (0)20 7260 1426 / +44 (0)7795 964 870

Vicki Paine                    +44 (0)20 7260 1256 / +44 (0)78 8431 1486

Company Secretary - Link Company Matters

Claire Jackson             +44 (0)7821 843993

LEI: 213800N1QUJ744P76D11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOADZMFMMGDGMZM